Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Search Query
Submit Search
Show Search
Stephen Taub
Latest articles
Premium
How Third Point Fared After Increasing Bets on Stocks
Stephen Taub
December 7, 2023
Premium
Prominent Hedge Funds Stand to Benefit From Biopharma’s Change of Plans
Stephen Taub
December 6, 2023
Premium
Biopharma Bonanza
Stephen Taub
December 5, 2023
Premium
Greenlight Suffers a Setback in November
Stephen Taub
December 4, 2023
Premium
Soleus Goes Activist
Stephen Taub
November 30, 2023
Premium
Hedge Funds Eye Next Biopharma IPO
Stephen Taub
November 29, 2023
Premium
Deerfield Launches New VC Fund
Stephen Taub
November 28, 2023
Premium
Narrow Trade
Stephen Taub
November 27, 2023
Premium
Hedgies Shop for Instacart
Stephen Taub
November 22, 2023
Premium
Stan Druckenmiller Condolidates His Stock Holdings
Stephen Taub
November 21, 2023
Premium
Third Point’s Credit Bet
Stephen Taub
November 20, 2023
Premium
A Look Into Tiger Descendants’ Activity in the Third-Quarter
Stephen Taub
November 16, 2023
Premium
TCI, Whale Rock and Other Hedge Funds Made Major Moves in the Third-Quarter
Stephen Taub
November 15, 2023
Premium
Bridgewater Launches Two Funds
Stephen Taub
November 13, 2023
Premium
Greenlight Sharply Cuts Its Market Bet
Stephen Taub
November 9, 2023
Premium
Icahn’s Investment Fund Plunges Deeper Into the Red
Stephen Taub
November 8, 2023
Premium
Third Point Slashes Market Exposure
Stephen Taub
November 7, 2023
Premium
Citadel Continues to Set the Pace
Stephen Taub
November 6, 2023